OGN

Organon & Co.

Pharmaceutical PreparationsNYSELarge accelerated filer

Total Trades

8

Buys

8

Sells

0

Largest Trade

$500K+

Insiders

6

Institutional Funds

552

Inst. Value

$1M+

Activist Filings

8

Insider Trades

InsiderTitleTypeValueSharesPriceDate
COX CARRIE SMITHExecutive ChairBUY$500K+65K$7.67Nov 13, 2025
COX CARRIE SMITHDirectorBUY$100K–$500K12K$8.07May 15, 2025
Falcione AaronCHROBUY$15K–$50K6K$8.77May 7, 2025
Weaver KirkeGen. Counsel & Cor…BUY$50K–$100K8K$9.21May 7, 2025
Karp DanielExecutive VPBUY$15K–$50K4K$8.24May 7, 2025
WALSH MATTHEW MCFOBUY$100K–$500K11K$8.82May 6, 2025
Ali KevinCEOBUY$100K–$500K34K$8.80May 6, 2025
Weaver KirkeGen. Counsel & Cor…BUY$15K–$50K3K$18.36Feb 23, 2024
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

The Vanguard Group

SC 13G/A · Oct 30, 2025

13.8%

35.9M shares

BlackRock, Inc.

SC 13G/A · Apr 30, 2025

11.9%

30.7M shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

12.0%

30.6M shares

BlackRock, Inc.

SC 13G/A · Jan 23, 2024

13.1%

33.5M shares

BlackRock, Inc.

SC 13G/A · Nov 7, 2023

12.7%

32.4M shares

Mawer Investment Management Ltd.

SC 13G · Feb 13, 2023

5.4%

13.7M shares

View on Google Finance →